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Abstract
Introduction: A national program of continuous 
ambulatory peritoneal dialysis (CAPD) has only recently 
been established in Sudan. In the head center of this 
national program, six of the 67 peritonitis episodes that 
were diagnosed during its 30 months of function were 
fungal in origin (9% of all episodes, 0.12 episode per 
year at risk). Here we describe the clinical features, 
predisposing factors, and outcomes of these six cases.  
Case series: Clinical presentation of fungal peritonitis 
did not differ from other cases of peritonitis. Among the 
six cases that were diagnosed in our center, five cases 
were due to Candida species and only one was due to 
Aspergillus. All patients had received antibiotic therapy 
within one month of diagnosing fungal peritonitis; five 
of them had received intraperitoneal (IP) antibiotics for a 
previous episode of bacterial peritonitis and one patient 
had received a course of oral antibiotics for exit site 
infection. Two of the patients were diabetic. All patients 
were treated with oral fluconazole, 200 mg daily, for three 
weeks, and all had their dialysis catheter removed. One 
patient died, and the others were transferred permanently 
to hemodialysis (HD). Two patients developed encysted 
intra-abdominal fluid collections 15 and 48 days after 
catheter removal.
Conclusion: Fugal peritonitis complicating CAPD 
is not uncommon in our center, which serves a major 
portion of the CAPD population in the Sudan. Most 
patients responded to oral fluconazole treatment and 
catheter removal, but two of them suffered from late 
complications.
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Introduction
Since continuous ambulatory peritoneal dialysis (CAPD) 
was introduced as a treatment modality for patients with 
end stage renal disease (ESRD), peritonitis has been one 
of the most important complications that can lead to 
technique failure. Fungal peritonitis is a rare but serious 
complication of CAPD, being responsible for 2.6-14.3% 
of all peritonitis episodes occurring in this set of patients 
[1-9]. Given the high complication rate that may result 
in mortality and technique failure, fungal peritonitis is 
considered to have a particularly poor prognosis [8-10].
There is no difference between the clinical presentation 
of bacterial and fungal peritonitis, although in fungal 
peritonitis the symptoms are usually milder and may 
be disregarded by the patient for several weeks before 
coming to hospital. Candida species constitute the most 
common isolate, accounting for 70-89% of cases [5-8]. 
Predisposition to fungal infections is multi-factorial; 
possible predisposing factors include diabetes mellitus, 
use of immunosuppressive drugs, a break in sterile 
technique and extensive use of antibiotics for bacterial 
peritonitis. Prior use of antibiotics have been found to 
contribute the most to fungal overgrowth [8,11], but this 
is not always the case [7]. 
Treatment of fungal peritonitis is often difficult, and 
immediate catheter removal in addition to systemic 
antifungal therapy is recommended by the international 
society of peritoneal dialysis (ISPD) [12].
CAPD has been introduced in Sudan in June 2005 as a 
national program [13]. Ribat PD center is the head center 
of the program and serves a major portion of CAPD 
patients enrolled up to date (82/196).
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During the 30 months of this center activity, 6 of 67 
peritonitis episodes were fungal in origin (9%). This is 
a rather high percentage compared to that reported from 
other centers in recent years [6-9]. Here we describe the 
clinical features, predisposing factors, and outcomes of 
those episodes.
Case Series
Between June 2005 and December 2007, 82 patients with 
ESRD underwent regular PD in our center; all of them 
were on CAPD. Peritoneal dialysis access was achieved 
with a Tenckhoff catheter; most catheters were inserted 
by open surgical dissection and a few were inserted by 
means of the modified Seldinger technique. 
During this period, 67 episodes of peritonitis were 
recorded; six of them were fungal in origin (9%). The 
six episodes occurred in six different patients; four males 
and two females, with a mean age of 57.2 years (range 
42 – 67 years). Their mean duration on CAPD was 10.8 
months (range 2.3 – 21.4 months). Two of them were 
diabetic. All patients had received antibiotics within one 
month of fungal peritonitis: Five patients had received 
intraperitoneal (IP) antibiotics for bacterial peritonitis 
and one patient had received oral antibiotics for exit site 
infection.
All patients presented with abdominal pain and cloudy 
effluent, three of them had fever, one had diarrhea and 
one had vomiting. The dialysate white cell count varied 
between 200-1905/mm3, with neutrophil predominance 
in all cases. 
Gram stain of the deposit yielded the diagnosis in the 
majority of cases. Culture was performed from the 
dialysate deposit on solid culture media (MacConkey, 
blood agar and chocolate agar) incubated for 72 hours at 
37°C. The interval between presentation and diagnosis of 
fungal peritonitis varied between 2 – 24 days; five cases 
were due to Candida species and only one case was due 
to Aspergillus; further identification of Candida subtypes 
was not feasible.
Upon diagnosis of fungal peritonitis, all patients were 
treated with oral fluconazole 200 mg once daily for three 
weeks, since no fluconazole preparation for intravenous 
or intraperitoneal use was available at the time. The 
catheter was removed in all patients, but no culture 
was done for its tip after its removal.The mean interval 
between the diagnosis of fungal peritonitis and catheter 
removal was 2.7 days (range 1-6 days). 
One of the two diabetic patients died from sepsis three 
days after catheter removal; in her case the catheter had 
been removed within 24 hours from diagnosis.
The other diabetic patient also had his catheter removed 
within 24 hours of diagnosis and was shifted to HD. He 
showed prompt clinical improvement but he presented 
again after two weeks with an abscess in the old tunnel 
tract that required surgical drainage, and an encysted 
fluid collection in the anterior abdominal wall that was 
aspirated under ultra-sound guidance. The encysted fluid 
did not re-accumulate and the patient has been doing well 
on HD since then.
Another patient had her catheter removed four days after 
the diagnosis of fungal peritonitis and was shifted to 
HD. She showed good initial response to treatment but 
presented again after 48 days with an encysted intra-
abdominal fluid collection that was aspirated under ultra-
sound guidance. 
The fourth patient with Candida peritonitis had 
concomitant Staphylococcus epidermidis peritonitis 
which was sensitive to cefazolin. He responded well to 
a combination of antifungal and antibacterial treatment 
with no complications, and was shifted permanently to 
HD.
The fifth and sixth patients responded well to treatment 
and had no immediate or long term complications in spite 
of the catheter being removed after 6 days of the diagnosis 
in one of them; both were transferred permanently to 
HD.
Discussion
The proportion of CAPD related peritonitis due to fungi 
is currently 9% in our center, which is comparable to that 
reported in the literature (2.6 – 14.3%) [1-9]; however, 
the proportions reported from most centers in more 
recent years are lower than ours [6-9]. The causative 
organism was Candida species in 5 of 6 patients (83.3%), 
in agreement with data from the literature (70 – 89.3%) 
[1-9]. 
All our patients had received antibiotics within one 
month of fungal peritonitis; five received intraperitoneal 
antibiotics for bacterial peritonitis and one received 
systemic antibiotics for exit site infection. Another 
predisposing factor was diabetes mellitus in two of the 
patients.  Intraperitoneal or systemic antibiotics were 
hence the major predisposing factor for fungal peritonitis 
in our patients. 
Several suggestions proposing to reduce the incidence of 
fungal peritonitis were raised. Avramovic et al attributed 
their low incidence of fungal peritonitis (2.6%) to the in-
hospital treatment of bacterial peritonitis episodes [14]. 
Prophylactic use of oral nystatin or fluconazole during 
antibiotic therapy has also been suggested to play a role 
in preventing fungal peritonitis [15].
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None of our patients resumed peritoneal dialysis. 
Brian et al [16] suggested that removal of the dialysis 
catheter and treatment with fluconazole may provoke the 
formation of massive peritoneal adhesions and recurrent 
peritoneal abscesses, as has happened to two of our 
patients. They believe that temporary discontinuation of 
peritoneal dialysis is neither essential nor desirable in 
the management of fungal peritonitis, and they suggest 
that peritoneal lavage with a temporary catheter and 
administration of intraperitoneal and oral antifungal 
agents offer an effective alternative regimen for the 
management of fungal peritonitis in CAPD patients. This 
approach, however, has not been verified so far.
Conclusion
Fugal peritonitis complicating CAPD is not uncommon 
in our center, which serves a major part of the CAPD 
population in the Sudan. Most of our infected 
patients responded to oral fluconazole treatment and 
catheter removal, but two of them suffered from late 
complications.
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